Human alveolar macrophage-derived chemotactic factor for neutrophils. Stimuli and partial characterization.

The presence of neutrophils within the lung is a characteristic feature of a variety of lung diseases. To evaluate the potential role of alveolar macrophages in modulating the migration of neutrophils to the lung, normal human alveolar macrophages obtained from volunteers by bronchopulmonary lavage, were exposed for various periods of time in vitro to heat-killed microorganisms, and noninfectious particulates, immune complexes, and the macrophage supernates were evaluated for chemotactic activity. The microorganisms, noninfectious particulates, and immune complexes were chosen as stimuli for alveolar macrophages because these stimuli are representative of a spectrum of pathogenic agents that cause neutrophil accumulation in the lower respiratory tract. After incubation with each of these stimuli, alveolar macrophages released low molecular weight (400-600) chemotactic factor(s) (alveolar macrophage-derived chemotactic factor[s] [AMCF]) with relatively more activity for neutrophils than monocytes or eosinophils. Checker-board analysis of the AMCF revealed that the factor was primarily chemotactic and not chemokinetic for neutrophils. The selectivity for neutrophils vs. monocytes could not be explained by a selective deactivation of monocytes, because the AMCF was more potent in deactivating neutrophils than monocytes. Partial characterization of AMCF demonstrated it was heterogeneous with the following features: (a) stable to heating at 56 and 100 degrees C for 30 min; (b) stable over a pH range of 1.0 to 12.0 for 60 min; (c) stable after exposure to trypsin, papain, chymotrypsin, collagenase, and elastase; (d) partially inhibited by serum chemotactic factor inhibitor(s); (e) two major isoelectric points (pI 7.6 and 5.2); and (f) partially extractable into ethyl acetate, ether, and hexane. Although AMCF was, at least, partially lipid in nature, it did not appear to be similar to previously described lipid chemotactic factors (e.g., hydroxy-derivatives of 5,8,10,14-eicosatetraenoic acid); analysis by gas chromatography-mass spectrophotometry of AMCF extracted into ethyl acetate did not reveal the presence of 5,8,10,14-eicosatetraenoic acid. The macrophage supernates containing the AMCF also stimulated normal human neutrophils to release lysozyme and lactoferrin but not lactate dehydrogenase. These studies suggest that a wide variety of potentially pathogenic stimuli induce normal alveolar macrophages to generate a low molecular weight chemotactic factor(s) that preferentially attracts neutrophils. Because alveolar macrophages are normal residents of alveoli, it is likely that by releasing this factor(s) macrophages play a significant role in amplifying the inflammatory processes seen in many acute and chronic lung diseases.

[1]  V. Ferrans,et al.  Maintenance of granuloma formation in pulmonary sarcoidosis by T lymphocytes within the lung. , 1980, The New England journal of medicine.

[2]  V. Ferrans,et al.  Inflammatory and immune processes in the human lung in health and disease: evaluation by bronchoalveolar lavage. , 1979, The American journal of pathology.

[3]  R. Crystal,et al.  Bronchoalveolar Lavage in Interstitial Lung Disease , 1978 .

[4]  A. Theofilopoulos,et al.  Circulating immune complexes in the idiopathic interstitial pneumonias. , 1978, The New England journal of medicine.

[5]  A. Fauci,et al.  Immunologic reactivity of the lung: the in vivo and in vitro generation of a neutrophil chemotactic factor by alveolar macrophages. , 1978, The American review of respiratory disease.

[6]  W. Roberts,et al.  Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. , 1977, The Journal of clinical investigation.

[7]  W. Roberts,et al.  Idiopathic pulmonary fibrosis. Clinical, histologic, radiographic, physiologic, scintigraphic, cytologic, and biochemical aspects. , 1976, Annals of internal medicine.

[8]  R. Simmons,et al.  Chemotaxis of human polymorphonuclear neutrophils under agarose: morphologic changes associated with the chemotactic response. , 1976, Journal of immunology.

[9]  M. Hamberg,et al.  Prostaglandin endoperoxides. Novel transformations of arachidonic acid in human platelets. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[10]  H. Showell,et al.  The ability of chemotactic factors to induce lysosomal enzyme release. II. The mechanism of release. , 1974, Journal of immunology.

[11]  C. Kirkpatrick,et al.  Chemotactic activity in dialyzable transfer factor. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[12]  G. Weissmann,et al.  MECHANISMS OF LYSOSOMAL ENZYME RELEASE FROM HUMAN LEUKOCYTES , 1973, The Journal of cell biology.

[13]  Sally H. Zigmond,et al.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. , 1973 .

[14]  S. Marney,et al.  C3 shunt activation in human serum chelated with EGTA. , 1972, Journal of immunology.

[15]  S. Malawista,et al.  THE MOBILIZATION AND EXTRACELLULAR RELEASE OF GRANULAR ENZYMES FROM HUMAN LEUKOCYTES DURING PHAGOCYTOSIS , 1972, The Journal of cell biology.

[16]  G. Green The J. Burns Amberson Lecture--in defense of the lung. , 1970, The American review of respiratory disease.

[17]  Kaplan Ap,et al.  A pre-albumin activator of prekallikrein. , 1970, Journal of immunology.

[18]  M. Yoshinaga,et al.  Immunoglobulin G as Possible Precursor of Chemotactic Factor , 1970, Nature.

[19]  P. Ward,et al.  C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. , 1970, Journal of immunology.

[20]  P. Ward,et al.  Bacterial factors chemotactic for polymorphonuclear leukocytes. , 1968, The American journal of pathology.

[21]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[22]  W. Reeves,et al.  AN IMPROVED PROCEDURE FOR THE PREPARATION OF CRYSTALLINE LACTIC DEHYDROGENASE FROM HOG HEART. , 1963, The Journal of biological chemistry.

[23]  W. Wood Studies on the cellular immunology of acute bacterial infections. , 1951, Harvey lectures.

[24]  Wood Wb STUDIES ON THE MECHANISM OF RECOVERY IN PNEUMOCOCCAL PNEUMONIA : I. THE ACTION OF TYPE SPECIFIC ANTIBODY UPON THE PULMONARY LESION OF EXPERIMENTAL PNEUMONIA , 1941 .